Coronavirus Disease (COVID-19) Updates

In response to the current outbreak of coronavirus disease (COVID-19) that was first reported from Wuhan, China, on December 31, 2019, Charles River has assembled a global team of internal experts who are closely monitoring the COVID-19 outbreak and its impact on employee safety and our business operations. To keep clients informed, we will post updates to this web page.

Charles River corporate headquarters

February 1, 2021 – As we start the new year, the COVID-19 pandemic continues to be disruptive in unprecedented ways. While we hope 2021 eventually brings some return to normalcy, our locations around the world have been doing an excellent job of providing a safe working environment while still meeting clients’ needs for research products and services. By nature of their status and work on critical COVID vaccines, therapies, and testing, several of our sites have qualified to receive immunizations for their staff, and we continue to work with local public health officials around the world on these efforts.

Charles River has been able to remain fully operational across all sites by adhering to the ongoing safety measures enacted at the start of the pandemic:

  • Employees work from home when possible
  • Strict visitor policies; we have also launched remote audits and virtual facility tours, and we are actively utilizing remote study monitoring to support clients who are unable to travel 
  • Restrictions on all non-essential business travel
  • Modified employee work schedules to create “time and distance” and separation of staff 
  • Physical distancing practices
  • Enhanced daily cleaning of common touch points (doorknobs, break areas, etc.) 
  • Reminders of good hygiene practices 
  • Requirement for face coverings for employees and visitors in accordance with applicable government guidance 
  • Employee self-monitoring for illness symptoms 
  • Testing, tracking, and contact tracing of COVID-19 cases 
  • Return to work and self-quarantine guideline documents 

Our global and site Business Continuity Plans are active, up to date, and helping our site-based operations, as well as associated logistics and support, to continue to meet our clients’ needs for planned and new projects, including work supporting COVID-19 research efforts.

For the latest business continuity updates, visit our COVID-19 web page. For continued learning, our digital education page has many helpful resources for researchers. If you have any other questions, please reach out to your usual Charles River contact.

Contact Us

Call us at:
United States and Canada: +1.877.CRIVER1 (+1.877.274.8371)

All other locations: 888.319.5343

Hours of coverage:
6 a.m.-6 p.m. ET

Email us at:
[email protected]

 

Related Resources

Business Operations Updates:

Compliance and Quality Assurance

Novel Coronavirus and Research Animals
(Updated April 28, 2020)

Visitor Notice
(Updated July 14, 2020)

COVID-19 UK Statement